HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

glycosylated recombinant human INF-beta

a phase I of a recombinant human beta-interferon for the treatment of patients with recurrent gliomas

Also Known As:

BG 9015; BG9015

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Related Diseases

1.	Glioma (Gliomas) 03/01/1997 - "We conclude that BG9015 has activity in patients with malignant gliomas, although the therapeutic index may be narrow. " 03/01/1997 - "A phase I trial of a new recombinant human beta-interferon (BG9015) for the treatment of patients with recurrent gliomas."
2.	Astrocytoma (Pilocytic Astrocytoma) 03/01/1997 - "On the basis of promising in vitro and clinical data demonstrating significant antiglioma activity of purified IFN-beta and a synthetic IFN-beta (Betaseron), we conducted a Phase I trial of a new, nonmutated, glycosylated recombinant human IFN-beta (BG9015) in patients with recurrent, high-grade astrocytomas. "

Related Drugs and Biologics

1.	Interferon-beta
2.	Interferon beta-1b (Betaseron)